Takayoshi Okabe Selected Research

Takayoshi Okabe Research Topics

Disease

11	Neoplasms (Cancer) 01/2021 - 01/2011
4	Infections 01/2022 - 04/2010
2	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 03/2011
2	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 03/2016
2	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 11/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2012 - 05/2011
1	Malaria 11/2022
1	Yellow Fever 01/2022
1	COVID-19 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Colitis 01/2021
1	Ulcerative Colitis 01/2021
1	Acute Promyelocytic Leukemia 01/2021
1	Alcoholism (Alcohol Abuse) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Hyperkalemia 01/2019
1	Dehydration (Water Stress) 01/2019
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 07/2017
1	Necrosis 07/2017
1	Pulmonary Arterial Hypertension 01/2017
1	Coma (Comas) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2015
1	Macular Degeneration (Age-Related Maculopathy) 08/2015
1	Choroidal Neovascularization 08/2015
1	Melanoma (Melanoma, Malignant) 11/2013
1	Prostatic Neoplasms (Prostate Cancer) 06/2012
1	Leukemia 03/2012
1	Communicable Diseases (Infectious Diseases) 03/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2011
1	Inflammation (Inflammations) 01/2011

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2012
3	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 04/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
2	EnzymesIBA 01/2022 - 01/2020
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2021 - 03/2011
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2015 - 06/2012
1	entinostat (MS 275)IBA 02/2024
1	Amyloid (Amyloid Fibrils)IBA 02/2024
1	Coenzyme A (CoA)IBA 11/2022
1	EcdysoneIBA 01/2022
1	FlavonoidsIBA 01/2022
1	SteroidsIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2022
1	daidzeinIBA 01/2022
1	NIMA-Interacting Peptidylprolyl IsomeraseIBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	H 77IBA 01/2021
1	regorafenibIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	CytokinesIBA 01/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	lysophosphatidic acidIBA 01/2020
1	Lysophosphatidic Acid ReceptorsIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2020
1	Disulfiram (Antabuse)FDA Link 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 01/2019
1	Uridine Diphosphate (UDP)IBA 07/2017
1	Interleukin-8 (Interleukin 8)IBA 07/2017
1	purinoceptor P2Y6IBA 07/2017
1	Epoprostenol ReceptorsIBA 01/2017
1	1,2,3,4-tetrahydroisoquinolineIBA 01/2017
1	norgestimate FDA LinkGeneric 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017
1	Sequestosome-1 ProteinIBA 12/2016
1	Diacylglycerol KinaseIBA 03/2016
1	IsoenzymesIBA 03/2016
1	Interleukin-2 (IL2)IBA 03/2016
1	Phosphotransferases (Kinase)IBA 12/2015
1	SRPIN803IBA 08/2015
1	Ointments (Pastes)IBA 08/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2015
1	human ERBB2 proteinIBA 10/2014
1	Growth Factor ReceptorsIBA 10/2014
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 08/2014
1	Cadherins (E-Cadherin)IBA 11/2013
1	Methotrexate (Mexate)FDA LinkGeneric 11/2013
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 03/2012
1	TenascinIBA 03/2012
1	Anaplastic Lymphoma KinaseIBA 05/2011
1	MAP Kinase Kinase Kinase 5IBA 01/2011
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 04/2010
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 04/2010
1	LuciferasesIBA 04/2010

Therapy/Procedure

3	Therapeutics 01/2020 - 05/2011
1	Oral Administration 01/2021
1	Drug Prescriptions 01/2019
1	Topical Administration 08/2015